Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Vaughn B Himes. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Vaughn B Himes har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:SGEN / Seagen Inc | Chief Technical Officer | 0 |
| US:ACHV / Achieve Life Sciences, Inc. | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Vaughn B Himes. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp ACHV / Achieve Life Sciences, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ACHV / Achieve Life Sciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ACHV / Achieve Life Sciences, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Vaughn B Himes som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-15 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | −119 471 | 0 | −100,00 | 229,00 | −27 358 859 | ||
| 2023-12-15 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | −14 874 | 0 | −100,00 | 229,00 | −3 406 146 | ||
| 2023-11-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −218 | 42 574 | −0,51 | 213,88 | −46 626 | 9 105 727 |
| 2023-11-13 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 567 | 42 792 | −16,68 | 213,31 | −1 827 427 | 9 127 962 |
| 2023-09-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −80 | 51 359 | −0,16 | 206,50 | −16 520 | 10 605 634 |
| 2023-09-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 785 | 51 439 | −14,59 | 205,76 | −1 807 602 | 10 584 089 |
| 2023-09-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 785 | 60 224 | 17,08 | 44,09 | 387 331 | 2 655 276 | |
| 2023-09-01 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 795 | 51 439 | −3,37 | 206,97 | −371 504 | 10 646 119 |
| 2023-08-30 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −371 | 53 234 | −0,69 | 206,00 | −76 426 | 10 966 204 |
| 2023-08-30 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 937 | 53 605 | 1,78 | ||||
| 2023-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | X | −1 198 | 52 668 | −2,22 | 193,87 | −232 255 | 10 210 687 |
| 2023-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | X | −869 | 53 866 | −1,59 | 193,87 | −168 472 | 10 442 942 |
| 2023-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | X | −658 | 54 735 | −1,19 | 193,87 | −127 566 | 10 611 414 |
| 2023-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 11 469 | 55 393 | 26,11 | ||||
| 2023-06-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −16 215 | 43 837 | −27,00 | 195,29 | −3 166 571 | 8 560 774 |
| 2023-06-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 16 215 | 60 052 | 36,99 | 41,04 | 665 464 | 2 464 534 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −25 000 | 43 837 | −36,32 | ||||
| 2023-04-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −243 | 68 837 | −0,35 | 205,86 | −50 023 | 14 170 551 |
| 2023-04-07 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 609 | 69 080 | 0,89 | ||||
| 2023-04-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1 214 | 68 471 | 1,81 | ||||
| 2023-03-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 691 | 67 257 | −3,85 | 177,92 | −478 783 | 11 966 365 |
| 2023-03-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 691 | 69 948 | 4,00 | 41,04 | 110 439 | 2 870 666 | |
| 2023-03-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −13 524 | 67 257 | −16,74 | 177,07 | −2 394 695 | 11 909 197 |
| 2023-03-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 13 524 | 80 781 | 20,11 | 41,04 | 555 025 | 3 315 252 | |
| 2022-09-01 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 789 | 67 183 | −2,59 | 154,41 | −276 248 | 10 374 029 |
| 2022-09-01 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 795 | 68 972 | −2,54 | 154,41 | −277 174 | 10 650 277 |
| 2022-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −869 | 70 767 | −1,21 | 170,22 | −147 917 | 12 045 612 |
| 2022-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −658 | 71 636 | −0,91 | 170,22 | −112 002 | 12 193 529 |
| 2022-08-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 12 014 | 72 294 | 19,93 | ||||
| 2022-06-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 134 | 119 471 | −0,94 | 160,00 | −181 440 | 19 115 360 |
| 2022-06-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 134 | 60 198 | 1,92 | 41,04 | 46 539 | 2 470 526 | |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 273 | 0 | −100,00 | ||||
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 298 | 1 273 | −50,49 | ||||
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 295 | 2 571 | −76,34 | ||||
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 273 | 59 064 | −2,11 | 138,61 | −176 451 | 8 186 861 |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 273 | 60 337 | 2,16 | 26,10 | 33 225 | 1 574 796 | |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 298 | 59 064 | −2,15 | 137,51 | −178 488 | 8 121 891 |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 298 | 60 362 | 2,20 | 26,10 | 33 878 | 1 575 448 | |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −8 295 | 59 064 | −12,31 | 136,40 | −1 131 438 | 8 056 330 |
| 2022-05-26 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 295 | 67 359 | 14,04 | 26,10 | 216 500 | 1 758 070 | |
| 2022-04-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −574 | 59 064 | −0,96 | 144,32 | −82 839 | 8 524 034 |
| 2022-03-16 | 3 | ACHV |
ACHIEVE LIFE SCIENCES, INC.
No securities are beneficially owned |
0 | ||||||||
| 2022-03-16 |
|
4 | ACHV |
ACHIEVE LIFE SCIENCES, INC.
Stock Option (right to buy) |
A - Award | 6 600 | 6 600 | |||||
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 157 | 10 866 | −9,62 | ||||
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 843 | 12 023 | −47,42 | ||||
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 157 | 59 500 | −1,91 | 127,67 | −147 714 | 7 596 365 |
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 157 | 60 657 | 1,94 | 26,10 | 30 198 | 1 583 148 | |
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −10 843 | 59 500 | −15,41 | 126,98 | −1 376 844 | 7 555 310 |
| 2022-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 10 843 | 70 343 | 18,22 | 26,10 | 283 002 | 1 835 952 | |
| 2021-12-22 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −345 | 59 500 | −0,58 | 149,85 | −51 698 | 8 916 075 |
| 2021-11-12 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 000 | 22 866 | −20,79 | ||||
| 2021-11-12 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −617 | 59 845 | −1,02 | 179,84 | −110 961 | 10 762 525 |
| 2021-11-12 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 366 | 60 462 | −5,27 | 178,82 | −601 908 | 10 811 815 |
| 2021-11-12 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 017 | 63 828 | −3,06 | 177,94 | −358 905 | 11 357 554 |
| 2021-11-12 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 000 | 65 845 | 10,03 | 26,10 | 156 600 | 1 718 554 | |
| 2021-11-03 |
|
4 | SGEN |
Seagen Inc.
Incentive Stock Option (right to buy) |
M - Exercise | −2 156 | 0 | −100,00 | ||||
| 2021-11-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 156 | 59 845 | 3,74 | 46,37 | 99 974 | 2 775 013 | |
| 2021-09-27 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 201 | 57 689 | 0,35 | 166,22 | 33 410 | 9 589 066 | |
| 2021-09-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 000 | 28 866 | −17,21 | ||||
| 2021-09-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −6 000 | 57 488 | −9,45 | 150,00 | −900 000 | 8 623 200 |
| 2021-09-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 6 000 | 63 488 | 10,44 | 26,10 | 156 600 | 1 657 037 | |
| 2021-09-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 795 | 57 488 | −3,03 | 167,52 | −300 690 | 9 630 131 |
| 2021-09-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 789 | 59 283 | −2,93 | 167,52 | −299 685 | 9 930 821 |
| 2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 20 626 | 20 626 | |||||
| 2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Incentive Stock Option (right to buy) |
A - Award | 642 | 642 | |||||
| 2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 8 718 | 61 072 | 16,65 | ||||
| 2021-08-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −658 | 52 354 | −1,24 | 154,55 | −101 697 | 8 091 520 |
| 2021-06-08 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −1 303 | 34 866 | −3,60 | ||||
| 2021-06-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 303 | 53 012 | −2,40 | 150,00 | −195 450 | 7 951 800 |
| 2021-06-08 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 1 303 | 54 315 | 2,46 | 26,10 | 34 008 | 1 417 622 | |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 697 | 0 | −100,00 | ||||
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 391 | 53 012 | −2,56 | 147,82 | −205 618 | 7 836 234 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −900 | 54 403 | −1,63 | 147,05 | −132 345 | 7 999 961 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 800 | 55 303 | −4,82 | 145,98 | −408 744 | 8 073 132 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 288 | 58 103 | −2,17 | 144,61 | −186 258 | 8 402 275 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 318 | 59 391 | −3,76 | 143,35 | −332 285 | 8 513 700 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 000 | 61 709 | −3,14 | 142,42 | −284 840 | 8 788 596 |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 10 697 | 63 709 | 20,18 | 15,46 | 165 376 | 984 941 | |
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | 9 941 | 120 605 | 8,98 | ||||
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | 56 995 | 110 664 | 106,20 | ||||
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −9 941 | 53 012 | −15,79 | ||||
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −9 941 | 53 012 | −15,79 | ||||
| 2021-06-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −56 995 | 72 894 | −43,88 | ||||
| 2021-03-04 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −12 000 | 10 697 | −52,87 | ||||
| 2021-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 992 | 129 889 | −1,51 | 154,23 | −307 226 | 20 032 780 |
| 2021-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −7 008 | 131 881 | −5,05 | 153,41 | −1 075 097 | 20 231 864 |
| 2021-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 000 | 138 889 | −2,11 | 152,10 | −456 300 | 21 125 017 |
| 2021-03-04 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 12 000 | 141 889 | 9,24 | 15,46 | 185 520 | 2 193 604 | |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | 8 131 | 53 669 | 17,86 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | 45 538 | 45 538 | |||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −8 131 | 129 790 | −5,90 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −8 131 | 129 790 | −5,90 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | −45 538 | 146 052 | −23,77 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 22 697 | −26,06 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Incentive Stock Option (right to buy) |
M - Exercise | −2 207 | 0 | −100,00 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Incentive Stock Option (right to buy) |
M - Exercise | −2 554 | 0 | −100,00 | ||||
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −200 | 191 590 | −0,10 | 183,26 | −36 652 | 35 110 783 |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −3 692 | 191 790 | −1,89 | 182,43 | −673 532 | 34 988 250 |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −2 554 | 195 482 | −1,29 | 181,48 | −463 500 | 35 476 073 |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | X | −1 554 | 198 036 | −0,78 | 180,41 | −280 357 | 35 727 675 |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8 000 | 199 590 | 4,18 | 15,46 | 123 680 | 3 085 661 | |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 554 | 191 590 | 1,35 | 39,15 | 99 989 | 7 500 748 | |
| 2020-12-09 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 2 207 | 189 036 | 1,18 | 45,30 | 99 977 | 8 563 331 | |
| 2020-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 30 697 | −20,67 | ||||
| 2020-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −734 | 186 829 | −0,39 | 148,31 | −108 860 | 27 708 609 |
| 2020-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 766 | 187 563 | −2,48 | 147,86 | −704 701 | 27 733 065 |
| 2020-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 500 | 192 329 | −1,28 | 146,73 | −366 825 | 28 220 434 |
| 2020-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 000 | 194 829 | 4,28 | 15,46 | 123 680 | 3 012 056 | |
| 2020-09-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 796 | 186 829 | −0,95 | 155,69 | −279 627 | 29 088 192 |
| 2020-09-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 789 | 188 625 | −0,94 | 155,69 | −278 537 | 29 367 818 |
| 2020-08-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −8 054 | 190 414 | −4,06 | 158,17 | −1 273 892 | 30 117 554 |
| 2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 15 719 | 15 719 | |||||
| 2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 636 | 636 | |||||
| 2020-08-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 6 596 | 198 468 | 3,44 | ||||
| 2020-07-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 38 697 | −17,13 | ||||
| 2020-07-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 965 | 191 840 | −1,01 | 180,18 | −354 054 | 34 565 731 |
| 2020-07-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 835 | 193 805 | −2,43 | 179,35 | −867 157 | 34 758 927 |
| 2020-07-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 200 | 198 640 | −0,60 | 178,46 | −214 152 | 35 449 294 |
| 2020-07-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 000 | 199 840 | 4,17 | 15,46 | 123 680 | 3 089 526 | |
| 2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
D - Sale to Issuer | X | −920 | 191 582 | −0,48 | 139,92 | −128 724 | 26 805 655 |
| 2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2 389 | 192 502 | 1,26 | ||||
| 2020-04-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1 439 | 190 113 | 0,76 | ||||
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 502 | 46 697 | −6,98 | ||||
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 498 | 0 | −100,00 | ||||
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −200 | 188 674 | −0,11 | 116,25 | −23 250 | 21 933 352 |
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 298 | 188 874 | −2,22 | 115,16 | −494 958 | 21 750 730 |
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 4 498 | 193 172 | 2,38 | 12,00 | 53 976 | 2 318 064 | |
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 502 | 188 674 | −1,82 | 114,53 | −401 084 | 21 608 833 |
| 2020-03-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 502 | 192 176 | 1,86 | 15,46 | 54 141 | 2 971 041 | |
| 2019-12-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 871 | 188 389 | 0,46 | ||||
| 2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 4 498 | −64,01 | ||||
| 2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 049 | 187 518 | −0,56 | 117,61 | −123 373 | 22 053 992 |
| 2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 951 | 188 567 | −3,56 | 117,09 | −813 893 | 22 079 310 |
| 2019-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 000 | 195 518 | 4,27 | 12,00 | 96 000 | 2 346 216 | |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 878 | 187 518 | −2,03 | 70,80 | −274 560 | 13 276 162 |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 814 | 191 396 | −0,94 | 70,80 | −128 430 | 13 550 684 |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 41 453 | 41 453 | |||||
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −8 000 | 12 498 | −39,03 | |||
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 1 333 | 1 333 | |||||
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −713 | 193 210 | −0,37 | 73,24 | −52 220 | 14 150 700 |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 287 | 193 923 | −3,62 | 72,82 | −530 639 | 14 121 473 |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | X | 8 000 | 201 210 | 4,14 | 12,00 | 96 000 | 2 414 520 |
| 2019-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 18 013 | 193 210 | 10,28 | ||||
| 2019-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 836 | 175 197 | −3,76 | 73,21 | −500 496 | 12 827 013 |
| 2019-06-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −2 268 | 0 | −100,00 | ||||
| 2019-06-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −2 436 | 0 | −100,00 | ||||
| 2019-06-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 436 | 182 033 | 1,36 | 41,04 | 99 973 | 7 470 634 | |
| 2019-06-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 268 | 179 597 | 1,28 | 44,09 | 99 996 | 7 918 432 | |
| 2019-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 20 498 | −28,07 | ||||
| 2019-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 560 | 177 329 | −1,42 | 66,50 | −170 240 | 11 792 378 |
| 2019-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 440 | 179 889 | −2,94 | 65,67 | −357 245 | 11 813 311 |
| 2019-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 000 | 185 329 | 4,51 | 12,00 | 96 000 | 2 223 948 | |
| 2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 000 | 28 498 | −21,92 | ||||
| 2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 343 | 177 329 | −1,85 | 69,05 | −230 834 | 12 244 567 |
| 2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 657 | 180 672 | −2,51 | 68,48 | −318 911 | 12 372 419 |
| 2019-03-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 8 000 | 185 329 | 4,51 | 12,00 | 96 000 | 2 223 948 | |
| 2018-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 36 498 | −12,05 | ||||
| 2018-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 000 | 177 329 | 2,90 | 12,00 | 60 000 | 2 127 948 | |
| 2018-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −400 | 172 329 | −0,23 | 62,76 | −25 104 | 10 815 368 |
| 2018-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 600 | 172 729 | −2,59 | 62,09 | −285 614 | 10 724 744 |
| 2018-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 41 498 | −10,75 | ||||
| 2018-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −3 600 | 177 329 | −1,99 | 77,32 | −278 352 | 13 711 078 | |
| 2018-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −1 400 | 180 929 | −0,77 | 76,15 | −106 610 | 13 777 743 | |
| 2018-09-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 000 | 182 329 | 2,82 | 12,00 | 60 000 | 2 187 948 | |
| 2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 41 343 | 41 343 | |||||
| 2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 1 301 | 1 301 | |||||
| 2018-09-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 17 953 | 177 329 | 11,26 | ||||
| 2018-08-29 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 530 | 159 376 | −3,35 | 74,23 | −410 502 | 11 830 767 |
| 2018-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 46 498 | −9,71 | ||||
| 2018-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 500 | 164 906 | −0,90 | 59,28 | −88 920 | 9 775 628 |
| 2018-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 500 | 166 406 | −1,48 | 58,33 | −145 825 | 9 706 462 |
| 2018-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 000 | 168 906 | −0,59 | 57,62 | −57 620 | 9 732 364 |
| 2018-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 000 | 169 906 | 3,03 | 12,00 | 60 000 | 2 038 872 | |
| 2018-03-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-qualified Stock Option (Right to buy) |
A - Award | 8 333 | 8 333 | |||||
| 2018-03-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −5 000 | 51 498 | −8,85 | ||||
| 2018-03-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −200 | 164 906 | −0,12 | 58,86 | −11 772 | 9 706 367 |
| 2018-03-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −4 800 | 165 106 | −2,83 | 58,09 | −278 832 | 9 591 008 |
| 2018-03-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 000 | 169 906 | 3,03 | 12,00 | 60 000 | 2 038 872 | |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 431 | 0 | −100,00 | ||||
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 400 | 2 431 | −75,27 | ||||
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −169 | 56 498 | −0,30 | ||||
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −2 431 | 164 906 | −1,45 | 60,35 | −146 711 | 9 952 077 |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 2 431 | 167 337 | 1,47 | 12,16 | 29 561 | 2 034 818 | |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −7 400 | 164 906 | −4,29 | 59,84 | −442 816 | 9 867 975 |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 7 400 | 172 306 | 4,49 | 12,16 | 89 984 | 2 095 241 | |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −169 | 164 906 | −0,10 | 60,37 | −10 203 | 9 955 375 |
| 2017-12-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 169 | 165 075 | 0,10 | 12,00 | 2 028 | 1 980 900 | |
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 836 | 9 831 | −41,02 | ||||
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 164 | 0 | −100,00 | ||||
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 164 | 164 906 | −1,88 | 52,72 | −166 806 | 8 693 844 |
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 164 | 168 070 | 1,92 | 9,23 | 29 204 | 1 551 286 | |
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 836 | 164 906 | −3,98 | 53,45 | −365 384 | 8 814 226 |
| 2017-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 836 | 171 742 | 4,15 | 12,16 | 83 126 | 2 088 383 | |
| 2017-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −6 377 | 164 906 | −3,72 | 47,89 | −305 423 | 7 898 090 |
| 2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 47 844 | 47 844 | |||||
| 2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 156 | 2 156 | |||||
| 2017-08-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 20 000 | 171 283 | 13,22 | ||||
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −9 400 | 3 164 | −74,82 | ||||
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −600 | 12 564 | −4,56 | ||||
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −9 400 | 151 283 | −5,85 | 62,54 | −587 876 | 9 461 239 |
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 9 400 | 160 683 | 6,21 | 9,23 | 86 762 | 1 483 104 | |
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −600 | 151 283 | −0,40 | 63,41 | −38 046 | 9 592 855 |
| 2017-06-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 600 | 151 883 | 0,40 | 9,23 | 5 538 | 1 401 880 | |
| 2017-04-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 13 164 | −43,17 | ||||
| 2017-04-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −10 000 | 151 283 | −6,20 | 62,75 | −627 527 | 9 493 417 |
| 2017-04-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 161 283 | 6,61 | 9,23 | 92 300 | 1 488 642 | |
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −3 831 | 0 | −100,00 | ||||
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −6 468 | 0 | −100,00 | ||||
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −5 333 | 0 | −100,00 | ||||
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 5 333 | 151 011 | 3,66 | 12,00 | 63 996 | 1 812 132 | |
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 6 468 | 145 678 | 4,65 | 15,46 | 99 995 | 2 252 182 | |
| 2016-12-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 831 | 139 210 | 2,83 | 26,10 | 99 989 | 3 633 381 | |
| 2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −30 000 | 23 164 | −56,43 | ||||
| 2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −1 427 | 135 379 | −1,04 | 66,08 | −94 301 | 8 946 345 | |
| 2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −28 573 | 136 806 | −17,28 | 65,29 | −1 865 443 | 8 931 640 | |
| 2016-12-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 30 000 | 165 379 | 22,16 | 9,23 | 276 900 | 1 526 448 | |
| 2016-09-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 9 600 | 135 379 | 7,63 | ||||
| 2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 40 293 | 40 293 | |||||
| 2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 207 | 2 207 | |||||
| 2016-08-30 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 17 000 | 125 779 | 15,63 | ||||
| 2016-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 991 | 108 779 | −3,54 | 46,59 | −185 943 | 5 068 090 |
| 2015-12-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −3 000 | 5 333 | −36,00 | ||||
| 2015-12-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −32 036 | 0 | −100,00 | ||||
| 2015-12-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 32 036 | 111 248 | 40,44 | 9,23 | 295 692 | 1 026 819 | |
| 2015-12-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 000 | 79 212 | 3,94 | 12,00 | 36 000 | 950 544 | |
| 2015-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −40 500 | 53 164 | −43,24 | ||||
| 2015-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −40 500 | 76 212 | −34,70 | 39,94 | −1 617 493 | 3 043 762 | |
| 2015-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 40 500 | 116 712 | 53,14 | 9,23 | 373 815 | 1 077 252 | |
| 2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 34 946 | 34 946 | |||||
| 2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 554 | 2 554 | |||||
| 2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 15 000 | 76 212 | 24,50 | ||||
| 2015-08-25 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −5 997 | 61 212 | −8,92 | 42,02 | −252 021 | 2 572 404 |
| 2015-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 93 664 | −17,60 | ||||
| 2015-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −20 000 | 67 209 | −22,93 | 36,65 | −732 992 | 2 463 183 | |
| 2015-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 20 000 | 87 209 | 29,76 | 9,23 | 184 600 | 804 939 | |
| 2014-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 113 664 | −8,09 | ||||
| 2014-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −10 000 | 67 209 | −12,95 | 37,52 | −375 169 | 2 521 473 | |
| 2014-11-14 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 77 209 | 14,88 | 9,23 | 92 300 | 712 639 | |
| 2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 35 232 | 35 232 | |||||
| 2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 268 | 2 268 | |||||
| 2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 15 000 | 67 209 | 28,73 | ||||
| 2014-08-27 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −3 310 | 52 209 | −5,96 | 43,55 | −144 147 | 2 273 650 |
| 2014-05-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 123 664 | −7,48 | ||||
| 2014-05-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −10 000 | 55 519 | −15,26 | 35,00 | −350 000 | 1 943 165 | |
| 2014-05-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 65 519 | 18,01 | 9,23 | 92 300 | 604 740 | |
| 2014-03-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
M - Exercise | −11 300 | 32 036 | −26,08 | ||||
| 2014-03-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 11 300 | 55 519 | 25,55 | 9,23 | 104 299 | 512 440 | |
| 2014-02-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 000 | 133 664 | −2,20 | ||||
| 2014-02-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −2 088 | 44 219 | −4,51 | 52,01 | −108 597 | 2 299 830 | |
| 2014-02-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −3 000 | 46 307 | −6,08 | 52,01 | −156 030 | 2 408 427 | |
| 2014-02-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 3 000 | 49 307 | 6,48 | 9,23 | 27 690 | 455 104 | |
| 2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 33 564 | 33 564 | 41,04 | 1 377 467 | 1 377 467 | ||
| 2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 2 436 | 2 436 | 41,04 | 99 973 | 99 973 | ||
| 2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 14 400 | 46 307 | 45,13 | ||||
| 2013-08-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | X | −1 736 | 31 907 | −5,16 | 40,91 | −71 020 | 1 305 315 |
| 2013-06-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 136 664 | −6,82 | ||||
| 2013-06-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −10 000 | 33 643 | −22,91 | 32,11 | −321 100 | 1 080 277 | |
| 2013-06-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 43 643 | 29,72 | 9,23 | 92 300 | 402 825 | |
| 2012-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 146 664 | −6,38 | ||||
| 2012-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | −10 000 | 33 643 | −22,91 | 28,79 | −287 900 | 968 582 | |
| 2012-09-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10 000 | 43 643 | 29,72 | 9,23 | 92 300 | 402 825 | |
| 2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 36 169 | 36 169 | 26,10 | 944 011 | 944 011 | ||
| 2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Incentive Stock Option (right to buy) |
A - Award | 3 831 | 3 831 | 26,10 | 99 989 | 99 989 | ||
| 2012-08-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 16 000 | 33 643 | 90,69 |
